Cargando…

Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature Review

BACKGROUND: Gallbladder carcinosarcoma (GBCS) is a rare and aggressive malignancy with extremely poor prognosis. Although surgery is regarded as the primary therapy for GBCS, the effective therapeutic strategies for unresected lesions have been poorly defined. CASE PRESENTATION: We presented a case...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qin-qin, Lin, Hao-ming, Han, Hong-wei, Yang, Cai-ni, Liu, Chao, Zhang, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967174/ https://www.ncbi.nlm.nih.gov/pubmed/35372010 http://dx.doi.org/10.3389/fonc.2022.803454

Ejemplares similares

Primary carcinosarcoma of the gallbladder
por: Park, Sung Bae, et al.
Publicado: (2012)

Carcinosarcoma of the ovary: a case report and literature review
por: Zheng, Jian, et al.
Publicado: (2023)

Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report
por: Wang, Hongming, et al.
Publicado: (2023)

Carcinosarcoma of the gallbladder—an exceedingly rare tumour
por: Cruz, João, et al.
Publicado: (2016)

Carcinosarcoma of gallbladder: A world review
por: Teng, Thomas Zheng Jie, et al.
Publicado: (2021)

Carcinosarcoma of the Gallbladder: A Rare Tumor
por: Mansour, Subhi, et al.
Publicado: (2022)

PD-L1 pathway as a novel target in carcinosarcoma of the kidney and renal pelvis
por: Raghavan, Ashwin M., et al.
Publicado: (2020)

Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report
por: Zhong, Liting, et al.
Publicado: (2022)

Surgical management of gallbladder carcinosarcoma: A case report and review of the Literature
por: Ayoub, Madani, et al.
Publicado: (2020)

Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review
por: Li, Jing, et al.
Publicado: (2021)

A rare case report of gallbladder carcinosarcoma
por: Trautman, Jodie, et al.
Publicado: (2018)

Gallbladder carcinosarcoma masquerading as a hepatic abscess
por: Khurram, Ruhaid, et al.
Publicado: (2020)

Efficacy and survival of anti-PD-1 antibody in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy as first-line treatment of HER2-positive metastasis gastric adenocarcinoma: a retrospective study
por: Deng, Ting, et al.
Publicado: (2023)

Case report: ZEB1 expression in three cases of hepatic carcinosarcoma
por: Zhang, Mingming, et al.
Publicado: (2022)

Case Report: A Case of Gallbladder Carcinosarcoma With Osteoclast-like Multinucleated Giant Cells that Was Associated With RANK‐RANKL Signaling
por: Niwa, Ayumi, et al.
Publicado: (2022)

Morphologic Heterogeneity in Carcinosarcoma of the Gallbladder: Report of a Rare Cases
por: Krishnamurthy, Vani, et al.
Publicado: (2011)

Two cases of resected gallbladder carcinosarcoma with a contrasting course
por: Kato, Toru, et al.
Publicado: (2022)

Gallbladder carcinosarcoma with two heterologous components: a case report
por: Tiabi, El Mehdi, et al.
Publicado: (2022)

Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review
por: Zhang, Zhe, et al.
Publicado: (2017)

Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma
por: Xu, Weiran, et al.
Publicado: (2022)

Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review
por: Yang, Hujuan, et al.
Publicado: (2023)

Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy
por: Yang, Ziyi, et al.
Publicado: (2022)

Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
por: Zhang, Chaoxu, et al.
Publicado: (2020)

Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel
por: Wei, Hangping, et al.
Publicado: (2021)

Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review
por: Zhang, Mengxi, et al.
Publicado: (2019)

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma
por: Xiang, Xiaoyong, et al.
Publicado: (2023)

Efficacy and safety of PD-1/PD-L1 inhibitor combined with chemotherapy versus chemotherapy alone in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis
por: Liu, Bo-Wei, et al.
Publicado: (2023)

Long-Term Survival of an Elderly Patient with Carcinosarcoma of the Gallbladder after Cholecystectomy
por: Kohtani, Takashi, et al.
Publicado: (2009)

Immunotherapy Combined With Chemotherapy for Postoperative Recurrent Penile Squamous Cell Carcinoma: A Case Report and Literature Review
por: Li, Na, et al.
Publicado: (2022)

Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review
por: Jia, Guohua, et al.
Publicado: (2022)

Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy
por: Peng, Ye, et al.
Publicado: (2021)

PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review
por: Liu, Sheng, et al.
Publicado: (2023)

The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors
por: Wu, Zhaozhen, et al.
Publicado: (2022)

Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling
por: Yu, Chao, et al.
Publicado: (2023)

Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery
por: Chen, Mingyu, et al.
Publicado: (2021)

PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series
por: Tan, Sirui, et al.
Publicado: (2022)

Carcinosarcoma of the Tunica Vaginalis Following Radiation Therapy for Localized Prostate Cancer
por: Viers, Charles D., et al.
Publicado: (2017)

Case Report: Niraparib as Maintenance Therapy in A Patient With Ovarian Carcinosarcoma
por: Zhang, Jie Qing, et al.
Publicado: (2021)

Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review
por: Liang, Bin, et al.
Publicado: (2023)

Gallbladder carcinosarcoma accompanied with bile duct tumor thrombi: A case report
por: WANG, YAN, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sgoqu7fer2besvvo21h32e9fku